Thermo-Chemical Evaluation of the Roselle Graft Copolymers
Polymers from Renewable Resources · 2010-11 · 1 (4) · 199-214
DOI: 10.1177/204124791000100403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polymers from Renewable Resources, online erschienen am 01.11.2010. Verfasst von Ashish Chauhan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
In this paper, the morphological transformations in Hibiscus sabdariffa (Roselle) stem fiber on graft copolymerization with Butyl acrylate (BA) and its binary mixture with Acrylic acid (AA) and Acrylamide (Aam), using ceric ammonium nitrate – nitric acid initiator system was reported. Different reaction parameters such as temperature, time, initiator concentration, monomer concentration and pH were optimized. The graft copolymers were characterized by FTIR, SEM, XRD, TGA and DTA techniques. The percentage crystallinity and crystallinity index were found to decrease with the increase in percentage grafting. The swelling behavior of graft copolymers in methanol, n-butanol, water and dimethyl formamide was studied and screened for dye uptake behavior in 0.1% gentian violet dye for seven hours. The graft copolymers were found to be moisture, chemical and thermal resistant. These graft copolymers could be utilized for various advanced applications.
Zitieren
APA
Chauhan, A., & Kaith, B. (2010). Thermo-Chemical Evaluation of the Roselle Graft Copolymers. Polymers from Renewable Resources, 1(4), 199-214. https://doi.org/10.1177/204124791000100403
Vancouver
Chauhan A, Kaith B. Thermo-Chemical Evaluation of the Roselle Graft Copolymers. Polymers from Renewable Resources. 2010;1(4):199-214. doi:10.1177/204124791000100403
BibTeX
@article{Chauhan2010,
author = {Chauhan, Ashish and Kaith, Balbir},
title = {Thermo-Chemical Evaluation of the Roselle Graft Copolymers},
journal = {Polymers from Renewable Resources},
year = {2010},
volume = {1},
number = {4},
pages = {199--214},
doi = {10.1177/204124791000100403}
}
EUVIMED